(29 days)
SnapshotNIR (KD204)
Kent Camera (KD203)
No
The summary describes multispectral imaging and spectral analysis at each pixel, which are traditional signal processing techniques, not AI/ML. There is no mention of AI, ML, or related concepts like training or test sets.
No
The device is described as a "non-invasive tissue oxygenation measurement system" intended to "report an approximate value of oxygen saturation... relative oxyhemoglobin level... and relative deoxyhemoglobin level." It "displays two-dimensional color-coded images of tissue oxygenation" and is indicated "to determine oxygenation levels in superficial tissues." This indicates a diagnostic or measurement function, not a therapeutic one (treatment or direct patient care to alleviate symptoms or restore health).
Yes
Explanation: The device is intended for use to determine oxygenation levels in superficial tissues, reporting approximate values of oxygen saturation (StO2), relative oxyhemoglobin level (HbO2), and relative deoxyhemoglobin (Hb) level. These measurements provide information about a patient's physiological state, which is indicative of a diagnostic function.
No
The device description explicitly states that SnapshotNIR (KD205) consists of hardware components including the SnapshotNIR device itself (which operates like a camera and uses LEDs), a recharger, and potentially a sterile drape. It also mentions form factor changes to accommodate hardware changes and the use of an embedded computer module and touchscreen LCD.
Based on the provided information, the SnapshotNIR (KD205) is not an In Vitro Diagnostic (IVD).
Here's why:
- Definition of IVD: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body, such as blood, urine, or tissue, to provide information for diagnosis, monitoring, or screening.
- SnapshotNIR's Function: SnapshotNIR is a non-invasive device that uses light to measure tissue oxygenation directly on the patient's body. It does not analyze specimens taken from the body.
- Intended Use: The intended use clearly states it's a "non-invasive tissue oxygenation measurement system" and is "indicated for use to determine oxygenation levels in superficial tissues." This describes a direct measurement on the patient, not an analysis of a sample.
Therefore, SnapshotNIR (KD205) falls under the category of a non-invasive medical device, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
SnapshotNIR (KD205) is intended for use by healthcare professive tissue oxygenation measurement system that reports an approximate value of:
- oxygen saturation (St02),
- relative oxyhemogoblin level (Hb02), and
- relative deoxyhemoglobin (Hb) level
in superficial tissue. SnapshotNIR (KD205) displays two-dimensional color-coded images of tissue oxygenation of the scanned surface and reports multispectral tissue oxygenation measurements for selected tissue regions.
SnapshotNIR (KD205) is indicated for use to determine oxygenation levels in superficial tissues.
Product codes
MUD
Device Description
SnapshotNIR (KD205) is a medical device that operates like a camera. The SnapshotNIR device is completely non-contact, capturing images from 12 inches away from the patient or other imaging field-ofviews. The device uses six near-infrared wavelengths of light and white light emitting diodes (LEDs) to produce a resultant tissue oxygenation image and a colour-based "RGB" or clinical image, respectfully, that can be viewed on the touchscreen display.
SnapshotNIR is based on multispectral imaging technology and performs spectral analysis at each pixel to determine the approximate values of tissue oxygen saturation (StO2), oxyhemoglobin levels (HbO2), and deoxyhemoglobin levels (Hb) in superficial tissues and displays a two-dimensional, color-coded image of the tissue oxygen saturation (StO2).
SnapshotNIR consists of:
- · SnapshotNIR
- · Recharger
- · User Guide
- · Quick Start Guide
- · Sterile Drape (Optional)
The intended use and user interaction remained the same in the new model (KD205). The user will notice that the modified device no longer requires the user to take a calibration image prior to image capture. SnapshotNIR now uses an embedded computer module and a touchscreen LCD. Additional minor form factor changes were made on the new model (KD205) to accommodate the hardware change. With respect to the software used by SnapshotNIR, the predicate and new model (KD205) operate similarly.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
near-infrared wavelengths of light, white light
Anatomical Site
superficial tissues
Indicated Patient Age Range
Not Found
Intended User / Care Setting
healthcare professionals
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Nonclinical engineering-based tests (e.g., IEC 60601-1-2, etc) among other performance bench tests support conclusions that the KD205 device is safe for use with a low risk of adverse events occurring during the intended use scenarios. These tests and findings are analogous to those conducted on the predicate KD204 SnapshotNIR device and demonstrate that the KD205 device is similarly safe, and effective compared to a current legally marketed device.
In a sub-analysis of the pre-clinical dataset, the KD205 device demonstrated no significant differences (derived via 2-way ANOVA models) in STO2 across the ischemia-reperfusion test when comparing cohorts of low versus high tissue scattering effects. This outcome is considered an improvement comparative to the KD204 device whereby non-physiological measurements were derived from the high tissue scattering cohort due to suboptimal signal-to-noise ratios of near-infrared light which impairs the calculation of STO2.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
SnapshotNIR (KD204)
Reference Device(s)
Kent Camera (KD203)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2700 Oximeter.
(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo in blue, with the words "U.S. FOOD & DRUG" stacked on top of the word "ADMINISTRATION".
April 2, 2024
Kent Imaging Inc % Dave Yungvirt CEO Third Party Review Group, LLC 25 Independence Blvd Warren, New Jersey 07059
Re: K240601
Trade/Device Name: SnapshotNIR model KD205 Regulation Number: 21 CFR 870.2700 Regulation Name: Oximeter Regulatory Class: Class II Product Code: MUD Dated: March 3, 2024 Received: March 4, 2024
Dear Dave Yungvirt:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn).
2
Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/deviceadvice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Tanisha L Tanisha L. Hit Hithe -S
Tanisha Hithe Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
3
Indications for Use
510(k) Number (if known) K240601
Device Name
SnapshotNIR (KD205)
Indications for Use (Describe)
SnapshotNIR (KD205) is intended for use by healthcare professive tissue oxygenation measurement system that reports an approximate value of:
- oxygen saturation (St02),
- relative oxyhemogoblin level (Hb02), and
- relative deoxyhemoglobin (Hb) level
in superficial tissue. SnapshotNIR (KD205) displays two-dimensional color-coded images of tissue oxygenation of the scanned surface and reports multispectral tissue oxygenation measurements for selected tissue regions.
SnapshotNIR (KD205) is indicated for use to determine oxygenation levels in superficial tissues.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
Image /page/4/Picture/0 description: The image shows the logo for Kent Imaging. The logo features a red square with a white stylized "K" inside. Below the square, the word "KENT" is written in a bold, sans-serif font, with the word "IMAGING" written in a smaller font size directly underneath.
510(k) Summary K240601
April 2, 2024
Device Name: SnapshotNIR (KD205)
Submittal Information:
Post-approval contact: Hitalo Arume
Kent Imaging Inc. Suite 300, 1210 8 Street SW Calgary, AB CANADA T2R 1L3
Phone: 403-455-7610 Fax: 877-664-5450
Device and Classification Name
| SnapshotNIR (KD205) | |
|---|---|
| Classification Name | Oximeter, Tissue Saturation |
| Classified Under | 21CFR 870.2700 |
| Classification of Device | Class II |
| Classification Panel | Cardiovascular |
| Product Code | MUD |
Predicate Device: SnapshotNIR (KD204)
Reference Device: Kent Camera (KD203)
Indications for Use
SnapshotNIR (KD205) is intended for use by healthcare professionals as a non-invasive tissue oxygenation measurement system that reports an approximate value of:
- oxygen saturation (St02),
- relative oxyhemogoblin level (Hb02), and
- relative deoxyhemoglobin (Hb) level
in superficial tissue. SnapshotNIR (KD205) displays two-dimensional color-coded images of tissue oxygenation of the scanned surface and reports multispectral tissue oxygenation measurements for selected tissue regions.
SnapshotNIR (KD205) is indicated for use to determine oxygenation levels in superficial tissues.
5
Image /page/5/Picture/0 description: The image shows the logo for Kent Imaging. The logo features a red square with a white stylized "K" inside. Below the square, the word "KENT" is written in a bold, sans-serif font, with the letters spaced slightly apart. Underneath "KENT", the word "IMAGING" is written in a smaller, less bold font.
Device Description
SnapshotNIR (KD205) is a medical device that operates like a camera. The SnapshotNIR device is completely non-contact, capturing images from 12 inches away from the patient or other imaging field-ofviews. The device uses six near-infrared wavelengths of light and white light emitting diodes (LEDs) to produce a resultant tissue oxygenation image and a colour-based "RGB" or clinical image, respectfully, that can be viewed on the touchscreen display.
SnapshotNIR is based on multispectral imaging technology and performs spectral analysis at each pixel to determine the approximate values of tissue oxygen saturation (StO2), oxyhemoglobin levels (HbO2), and deoxyhemoglobin levels (Hb) in superficial tissues and displays a two-dimensional, color-coded image of the tissue oxygen saturation (StO2).
SnapshotNIR consists of:
- · SnapshotNIR
- · Recharger
- · User Guide
- · Quick Start Guide
- · Sterile Drape (Optional)
The intended use and user interaction remained the same in the new model (KD205). The user will notice that the modified device no longer requires the user to take a calibration image prior to image capture. SnapshotNIR now uses an embedded computer module and a touchscreen LCD. Additional minor form factor changes were made on the new model (KD205) to accommodate the hardware change. With respect to the software used by SnapshotNIR, the predicate and new model (KD205) operate similarly.
Fundamental Principles
The SnapshotNIR (KD205) has identical fundamental working principles to the predicate camera. SnapshotNIR builds on the standard principles used in other oximeters and tissue oxygenation measurement systems. Tissue oxygenation devices expose tissue with light of known wavelengths and capture reflected light that is not absorbed by the tissue. Wavelengths are chosen to provide spectral information about the hemoglobin oxygen content. Tissue oxygen saturation (StO2) is calculated as:
$$StO_2 = \frac{[HbO_2]}{[Hb] + [HbO_2]}$$
For viable (blood-perfused) tissue, hemoglobin is a dominant absorber of light within the near infrared (near-IR) region of the electromagnetic spectrum, specifically between 600nm to 1000nm. The well documented and established absorption spectra exhibited by oxygenated hemoglobin (HbO2) and deoxygenated hemoglobin (Hb) enables near-IR spectroscopy to determine the proportions of HbO2 and Hb within the tissue. SnapshotNIR visualizes the tissue oxygen saturation levels at each image pixel reflected from the superficial capillary bed of the tissue being imaged based on the reflectance characteristics of HbO2 and Hb.
6
Image /page/6/Picture/0 description: The image contains the logo for Kent Imaging. The logo features a red square with a white stylized "K" inside, positioned above the word "KENT" in a bold, sans-serif font. Below "KENT" is the word "IMAGING" in a smaller, less bold font. The overall design is clean and professional, suggesting a company involved in imaging technology or services.
Nonclinical data
Nonclinical engineering-based tests (e.g., IEC 60601-1-2, etc) among other performance bench tests support conclusions that the KD205 device is safe for use with a low risk of adverse events occurring during the intended use scenarios. These tests and findings are analogous to those conducted on the predicate KD204 SnapshotNIR device and demonstrate that the KD205 device is similarly safe, and effective compared to a current legally marketed device.
Finally, the KD205 SnapshotNIR device has made improvements over the predicate KD204 device. In a sub-analysis of the pre-clinical dataset, the KD205 device demonstrated no significant differences (derived via 2-way ANOVA models) in STO2 across the ischemia-reperfusion test when comparing cohorts of low versus high tissue scattering effects. This outcome is considered an improvement comparative to the KD204 device whereby non-physiological measurements were derived from the high tissue scattering cohort due to suboptimal signal-to-noise ratios of near-infrared light which impairs the calculation of STO2.
Substantial Equivalence
The modified device (SnapshotNIR, model KD205) has the same regulatory information as the predicate device (Snapshotsin, model KD204) and the same regulatory information as the reference device (Kent Camera, model KD203).
| Comparative Feature | SnapshotNIR - KD205 | Predicate SnapshotNIR – KD204 |
|---|---|---|
| Indications for Use | Same | SnapshotNIR is intended for use by healthcare professionals as a non-invasive tissue oxygenation measurement system that reports an approximate value of oxygen saturation (StO2), oxyhemoglobin level (HbO2), and deoxyhemoglobin (Hb) level in superficial tissue. SnapshotNIR displays two-dimensional color-coded images of tissue oxygenation of the scanned surface and reports multispectral tissue oxygenation measurements for selected tissue regions. SnapshotNIR is indicated for use to determine oxygenation levels in superficial tissues. |
| Measurements | Same | Oxygen saturation Oxyhemoglobin level Deoxyhemoglobin level |
| Method of Measurement | Same | Non-invasive, non-patient contacting imaging head illuminates the surface and receives returned light. |
| Same | 6 wavelengths between 600nm and 1000nm. | |
| Comparative Feature | SnapshotNIR - | |
| KD205 | Predicate SnapshotNIR – KD204 | |
| Same | A CMOS image sensor with global shutter is | |
| used as the detector. | ||
| Same | Spectral analysis at specific wavelengths of light | |
| returned from the target tissue. | ||
| Light Source | Same | LEDs |
| Lens | Same | Corrected and optimized for use from 400nm to |
| 1000nm. | ||
| Output Display | Same | Two-dimensional color-coded map of |
| • estimated oxygen saturation | ||
| • Numeric data | ||
| Power Source | Same | DC (battery-powered) |
| Patient Contact | Same | None |
| Control Method | Same | Computer controlled. |
| Calibration | Device is factory | |
| calibrated to | ||
| account for range | ||
| of operating | ||
| conditions. | Preformed at start-up by operator and repeated if | |
| operating conditions of camera change to the | ||
| degree that necessitates recalibration. | ||
| Sterility | Same | Device is not considered sterile. |
| Software Language | Same | C# |
| Selection Tools | Same | Circle |
| Region/Perimeter | ||
| Line | ||
| Region of Interest (ROI) Area | Same | Support freehand drawing ROI selection (cm2). |
| User Interface | Embedded CPU, | |
| touchscreen LCD | ||
| and battery | ||
| incorporated into | ||
| camera enclosure. | Off-the-shelf touchscreen PC incorporated in | |
| enclosure with camera and battery. | ||
| System Components | Camera and | |
| recharger. | Camera, calibration card and recharger. | |
| Data storage | Same | Patient images are stored in a proprietary secure |
| format on the device and patient information is | ||
| stored in an encrypted database on the device. | ||
| Patient images and database are hidden on | ||
| device. | ||
| Comparative Feature | SnapshotNIR - KD205 | Predicate SnapshotNIR – KD204 |
| Connectivity and Reporting | Same | User can create reports and email through Wi-Fi connectivity. |
| Software upgrades performed via USB or through cloud. | ||
| Log files can also be uploaded to cloud for support. | Software upgrades performed via USB. | |
| Expiration Date | Same | No expiration date. |
Detailed Comparative Features between Devices.
7
Image /page/7/Picture/0 description: The image shows the logo for Kent Imaging. The logo features a red square with a white "K" inside it. Below the square is the word "KENT" in a bold, blue font. Underneath "KENT" is the word "IMAGING" in a smaller, less bold, blue font.
8
Image /page/8/Picture/0 description: The image shows the logo for Kent Imaging. The logo features a red square with a stylized white "K" inside. Below the square, the word "KENT" is written in a bold, sans-serif font. Underneath "KENT", the word "IMAGING" is written in a smaller, sans-serif font.
Conclusion
The modified SnapshotNIR (KD205) is substantially equivalent to the predicate Snapshotsm (KD204)